ARTICLE | Company News
Europe approves expanded Visudyne use
March 23, 2001 8:00 AM UTC
QLT (QLTI; TSE:QLT) and partner Novartis Ophthalmics (Bulach, Switzerland) received European marketing approval for Visudyne verteporfin injection to treat subfoveal choroidal neovascularization (CNV)...